SCHEMBL15038014

SCHEMBL15038014

Nc1ccc2c(c1)N(CCNCCN1CCOCC1)CCC2

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.42
CD274 Q9NZQ7 1/20 0.40
HPGD P15428 1/20 0.39
ALOX15 P16050 1/20 0.39
HTT P42858 1/20 0.39
ALDH1A1 P00352 1/20 0.38
CYP3A4 P08684 2/20 0.38
THRB P10828 2/20 0.38
USP2 O75604 1/20 0.38
BRD4 O60885 1/20 0.38
ATAD2 Q6PL18 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
REN P00797 1/20 0.37
HRH3 Q9Y5N1 1/20 0.36
MAPK1 P28482 1/20 0.36
MAPT P10636 2/20 0.35
GAA P10253 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NOS3 P29474 2/20 0.35
NOS1 P29475 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15037980 0.94 KDM1A (0.43) KDM1ACD274HPGDALOX15HTT
SCHEMBL20144775 0.91 KDM1A (0.41) KDM1AHPGDALOX15HTTALDH1A1
SCHEMBL15038009 0.90 HRH3 (0.44) KDM1AALDH1A1CYP3A4BRD4ATAD2
SCHEMBL4422995 0.90 BRD4 (0.42) CD274HPGDALOX15HTTALDH1A1
SCHEMBL15038011 0.89 HRH3 (0.46) KDM1AALDH1A1CYP3A4BRD4ATAD2
SCHEMBL15038010 0.88 KDM1A (0.41) KDM1AALDH1A1CYP3A4BRD4ATAD2
SCHEMBL15037984 0.84 HRH3 (0.46) KDM1ACYP3A4BRD4ATAD2REN
SCHEMBL20144734 0.84 BRD4 (0.44) ALDH1A1CYP3A4BRD4ATAD2REN
SCHEMBL15037630 0.84 REN (0.38) KDM1AALDH1A1CYP3A4BRD4ATAD2
SCHEMBL15037987 0.83 HRH3 (0.48) KDM1ACYP3A4BRD4ATAD2REN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2791116-B1 COUPLER WITH 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE STRUCTURE, DYEING COMPOSITION COMPRISING SAME, PROCESSES AND USES OREAL (FR) 2018-05-16 EP claimed
EP-2791116-B1 COUPLER WITH 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE STRUCTURE, DYEING COMPOSITION COMPRISING SAME, PROCESSES AND USES OREAL (FR) 2018-05-16 EP disclosed
EP-2791116-B1 COUPLER WITH 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE STRUCTURE, DYEING COMPOSITION COMPRISING SAME, PROCESSES AND USES OREAL (FR) 2018-05-16 EP disclosed
US-9233060-B2 Coupler with 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses L'OREAL (FR) 2016-01-12 US disclosed
US-9233060-B2 Coupler with 7-amino-1,2,3,4-tetrahydroquinoline structure, dyeing composition comprising same, processes and uses L'OREAL (FR) 2016-01-12 US disclosed
US-20150000691-A1 COUPLER WITH 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE STRUCTURE, DYEING COMPOSITION COMPRISING SAME, PROCESSES AND USES L'OREAL (FR) 2015-01-01 US disclosed
US-20150000691-A1 COUPLER WITH 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE STRUCTURE, DYEING COMPOSITION COMPRISING SAME, PROCESSES AND USES L'OREAL (FR) 2015-01-01 US disclosed
WO-2013087932-A1 COUPLER WITH 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE STRUCTURE, DYEING COMPOSITION COMPRISING SAME, PROCESSES AND USES L'OREAL (FR) 2013-06-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150000691-A1 COUPLER WITH 7-AMINO-1,2,3,4-TETRAHYDROQUINOLINE STRUCTURE, DYEING COMPOSITION COMPRISING SAME, PROCESSES AND USES KRT18, COL1A1, PYCR1 KDM1A 315/4885CD274 2382/4885HPGD 1875/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.